Robert W. Baird's Rating of Sensei Biotherapeutics on 6/25/2026

On June 25, 2026, Robert W. Baird updated its outlook on Sensei Biotherapeutics (NASDAQ:FTH) with the action "Upgrade", setting a "Strong-Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Robert W. Baird

DateCompanyAction
6/26/2026
Caterpillar Inc. stock logo
CAT
Caterpillar
Boost Price Target
6/26/2026
FTH
Sensei Biotherapeutics
Initiated Coverage
6/26/2026
Visteon Corporation stock logo
VC
Visteon
Reiterated Rating
6/26/2026
Darden Restaurants, Inc. stock logo
DRI
Darden Restaurants
Boost Price Target
6/26/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
Boost Price Target
6/26/2026
Acuity, Inc. stock logo
AYI
Acuity
Boost Price Target
More Ratings From Robert W. Baird